Defective Modulation of LINE-1 Retrotransposition by Cancer-Associated SAMHD1 Mutants.

Wenying Gao,Guangquan Li,Xuefeng Bian,Yajuan Rui,Chenyang Zhai,Panpan Liu,Jiaming Su,Hong Wang,Chunfeng Zhu,Yanjia Du,Wenwen Zheng,Baisong Zheng,Wenyan Zhang,Hui Zhang,Ke Zhao,Yongjun Yang,XiaoFang Yu
DOI: https://doi.org/10.1016/j.bbrc.2019.08.155
IF: 3.1
2019-01-01
Biochemical and Biophysical Research Communications
Abstract:Long interspersed nuclear elements (LINE-1) is now considered as the only active autonomous mobile DNA in humans, LINE-1 retrotransposition activities are associated with and fluctuate during cancer initiation and progression; however, the mechanism underlying the increased LINE-1 activity in cancer is poorly understood. SAMHD1 has been reported to be a potent inhibitor of LINE-1 retrotransposition, and SAMHD1 mutations are frequently associated with cancer development. To gain insights on whether cancer-related SAMHD1 mutants affect LINE-1 activity, we explored the biochemical and cellular properties of some human mutants known correlate with the development of cancer. Most of the tested SAMHD1 cancer-related mutations were defective in LINE-1 inhibition. Interestingly we also found that SAMHD1 mutant K288T was defective for dNTPase activity but showed potent activity against LINE-1 retrotransposition. These findings suggest that LINE-1 inhibition does not depend solely on the dNTPase activity of SAMHD1. In contrast, SAMHD1's ability to inhibit ORF2p-mediated LINE-1 RNP reverse transcription was correlated with SAMHD1-mediated LINE-1 inhibition. Together, our data could also facilitate the deeper understanding for the inhibition of endogenous LINE-1 elements by SAMHD1.
What problem does this paper attempt to address?